Nivolumab-Induced Fulminant Immune-Related Colitis Despite Infliximab in a Patient With NSCLC.
作者信息
Callens Rutger, Tamsin An, van Zandweghe Luc
机构信息
Department of Pneumology, AZ Sint-Blasius Hospital, Dendermonde, Belgium.
Department of Pathology, AZ Sint-Blasius Hospital, Dendermonde, Belgium.
出版信息
J Thorac Oncol. 2019 Mar;14(3):e49-e50. doi: 10.1016/j.jtho.2018.11.014.
PMID:30782382
Abstract
摘要
相似文献
1
Nivolumab-Induced Fulminant Immune-Related Colitis Despite Infliximab in a Patient With NSCLC.
J Thorac Oncol. 2019 Mar;14(3):e49-e50. doi: 10.1016/j.jtho.2018.11.014.
2
Nivolumab-Induced Colitis Treated by Infliximab.
Clin Gastroenterol Hepatol. 2017 Apr;15(4):e80-e81. doi: 10.1016/j.cgh.2016.09.017. Epub 2016 Sep 21.
3
Nivolumab-Induced Hemophilia A Presenting as Gastric Ulcer Bleeding in a Patient With NSCLC.
J Thorac Oncol. 2018 Dec;13(12):e239-e241. doi: 10.1016/j.jtho.2018.06.024. Epub 2018 Jul 12.
4
Immune Thrombocytopenia Induced by Nivolumab in a Metastatic Non-Small Cell Lung Cancer Patient.
Oncol Res Treat. 2017;40(10):621-622. doi: 10.1159/000477968. Epub 2017 Sep 19.
5
Widespread Nivolumab-induced Enteropathy in a Long Responder Non-Small-cell Lung Cancer Patient.
Clin Lung Cancer. 2018 Sep;19(5):e591-e596. doi: 10.1016/j.cllc.2018.04.013. Epub 2018 May 5.
6
[Fulminant myocarditis caused by nivolumab treatment for non-small cell lung cancer (NSCLC): a case report].
Zhonghua Zhong Liu Za Zhi. 2020 Dec 23;42(12):1047-1048. doi: 10.3760/cma.j.cn112152-20200116-00042.
7
Eczematous reactions mimicking psoriasiform dermatitis induced by nivolumab for advanced lung cancer.
Australas J Dermatol. 2019 Feb;60(1):e67-e68. doi: 10.1111/ajd.12868. Epub 2018 Jun 13.
8
Stevens-Johnson syndrome during nivolumab treatment of NSCLC.
Ann Oncol. 2018 Jan 1;29(1):283-284. doi: 10.1093/annonc/mdx640.
9
Development of mild drug-induced sclerosing cholangitis after discontinuation of nivolumab.
Eur J Cancer. 2019 Jan;107:93-96. doi: 10.1016/j.ejca.2018.11.021. Epub 2018 Dec 13.
10
Frequency and imaging features of abdominal immune-related adverse events in metastatic lung cancer patients treated with PD-1 inhibitor.
Abdom Radiol (NY). 2019 May;44(5):1917-1927. doi: 10.1007/s00261-019-01935-2.
引用本文的文献
1
Treatment of immune checkpoint inhibitor-related colitis: a narrative review.
Transl Cancer Res. 2024 Dec 31;13(12):7002-7014. doi: 10.21037/tcr-24-2150. Epub 2024 Dec 27.
2
Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach.
Inflamm Bowel Dis. 2024 Jun 3;30(6):1018-1031. doi: 10.1093/ibd/izad229.
3
Pharmacological Treatments Available for Immune-Checkpoint-Inhibitor-Induced Colitis.
Biomedicines. 2022 Jun 6;10(6):1334. doi: 10.3390/biomedicines10061334.
4
Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management.
Front Immunol. 2021 Dec 21;12:800879. doi: 10.3389/fimmu.2021.800879. eCollection 2021.
Zotero 插件